Skip to main content
. 2019 Jan 7;11(2):241–253. doi: 10.4168/aair.2019.11.2.241

Table 3. Clinical and laboratory features of pediatric SCARs.

Characteristic DRESS (n = 7) SJS (n = 36) TEN (n = 4)
Cutaneous lesion extent (%) 99 (91.0–100) 67.5 (37.1–100) 99.5 (97.9–100)
Cutaneous findings
Rash 5 (71.4) 34 (94.4) 4 (100)
Target sign 5 (13.9) 2 (50)
Desquamation 8 (22.2) 2 (50)
Blister 20 (55.6) 3 (75)
Nikolsky signs 5 (13.9) 4 (100)
Skin detachment
Day 1 1 (14.3) 6 (16.7) 1 (25.0)
Day 7 5 (13.9) 1 (25.0)
Tachycardia*
Day 1 6 (16.7) 1 (25.0)
Day 7 2 (50.0)
Mucosa involvement 1 (14.3) 33 (91.7) 4 (100)
Oral 1 23 3
Labial 19 4
Ocular 12 4
Genital 6 2
Respiratory 4 1
Lymphadenitis 1 (14.3) 1 (2.8) 2 (50)
Fever 6 (85.7) 24 (66.7) 3 (75)
Fever duration (day) 5.0 (4.0–8.0) 4.0 (2.0–6.0) 13 (10–21.5)
Hematologic finding
Leukocytosis 3 (42.9) 2 (5.6) 1 (25)
Leukopenia 2 (28.6) 10 (27.8) 2 (50)
Atypical lymphocytosis§ 2 (28.6) 2 (5.6) 1 (25)
Eosinophilia 3 (42.9) 4 (11.1) 3 (75)
Thrombocytopenia 2 (28.6) 7 (19.4) 2 (50)
Liver function abnormality** 7 (100) 13 (36.1) 2 (50)
Renal function abnormality†† 1 (2.8) 1 (25)

Values are presented as median (IQR) or number (%).

SCARs, severe cutaneous adverse reactions; DRESS, drug reaction with eosinophilia and systemic symptoms; SJS, Stevens-Johnson syndrome; TEN, toxic epidermal necrolysis; IQR, interquartile range.

*Tachycardia: heart rate > 160 beats/min in 0–2 years and heart rate > 120 beats/min in > 2 years; Leukocytosis: white blood cell count > 20,000/μL; Leukopenia: white blood cell count < 4,000/μL; §Atypical lymphocytosis: atypical lymphocyte ≥ 5%; Eosinophilia: eosinophil > 4%; Thrombocytopenia: platelet < 150,000/μL; **Abnormalities in liver function tests: serum level of alanine transaminase > 40 IU/L; ††Abnormalities in renal function tests: glomerular filtration rate < 100 mL/min/1.73 m2.